Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
26%
ALSO IN THNR
THNR
18
HOLDINGS
39%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 19.1% | 10.6% | 10.6% |
|
ABBVIE INC | 10.3% | 5.7% | 5.7% |
|
AMGEN INC | 4.7% | 5.9% | 4.7% |
|
MERCK & CO. INC. | 4.7% | 5.3% | 4.7% |
 |
ASTRAZENECA PLC | 4.5% | 5.5% | 4.5% |
MEDX Overweight Relative to THNR
|
ELI LILLY & CO | 8.5% |
 |
NOVARTIS AG-ADR | 6.7% |
|
JOHNSON & JOHNSON | 6.1% |
|
ABBVIE INC | 4.6% |
 |
ALKERMES PLC | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.3% |
|
BIOGEN IDEC INC | 3.4% |
|
ALNYLAM PHARMACEUTICALS INC | 2.8% |
|
IONIS PHARMACEUTICALS, INC. | 2.7% |
|
CRISPR THERAPEUTICS AG | 2.7% |
MEDX Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -8.9% |
|
GILEAD SCIENCES INC | -5.5% |
 |
CHINA PHARMACEUTICAL GROUP | -5.4% |
 |
INNOVENT BIOLOGICS, INC. | -5.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.7% |
|
VIKING THERAPEUTICS, INC. | -4.7% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -4.0% |
|
ZEALAND PHARMA A/S | -3.7% |
 |
HANMI PHARM CO LTD | -3.5% |
|
REGENERON PHARMACEUTICALS | -2.5% |